Hey there! We’re thrilled to share that we’re kicking off a six-month study to explore the effectiveness of progesterone gel versus tablets for women after in vitro fertilization (IVF). You might know that progesterone is a hormone produced by the ovaries post-ovulation, and it’s crucial for helping embryos implant and thrive during those early weeks of pregnancy. Traditionally, progesterone is delivered through vaginal suppositories, but now we’re looking into a new option called Endometrin, which is an effervescent tablet inserted vaginally for localized absorption.
This study aims to see if this new delivery method can be just as effective as the current FDA-approved options. We’re on the lookout for up to 25 women dealing with infertility to participate. If you’re a non-smoker aged 18 to 42, with two functioning ovaries and a Body Mass Index (BMI) of 34 or less, you might be eligible! Plus, participants who qualify and go through an IVF cycle will receive free medications and reduced fees.
If you’re interested, check out more about women’s fertility through our other blog posts, such as this fun tool for predicting baby gender.
For those curious about home insemination, you might want to look at this great artificial insemination kit for a more personalized approach. And if you want to dive deeper into the IVF process, this article is a fantastic resource.
In summary, our study aims to shed light on new progesterone options for women undergoing IVF, and we’re eager for eligible participants to join us in this exciting research!